- Current or recent (within 30 days prior to start of trial treatment) treatment with another investigational drug or participation in another investigational trial. EXCEPTION: Patients may be eligible after a future amendment for a separate future targeted therapy protocol in addition to the current treatment protocol, i.e. radiotherapy and temozolomide plus VPA or CQ. These patients will then be stratified within the randomized arms of the current protocol.